Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project

Fig. 3

Subgroup analysis for association between the type of discrepancy and in-hospital outcomes*. * A categorized variable to compare the increased FPG group with the increased HbA1c group was used in logistic regression analysis. ORs were adjusted for age, gender, systolic blood pressure, heart rate, current smoker, hypertension, hemoglobin at admission, eGFR at admission, Killip class, type of acute coronary syndrome, and glucose-lowering drug use. Panel a shows the effect of the increased FPG group on MACCE compared with increased HbA1c group. Panel b shows the effect of the increased FPG group on heart failure compared with increased HbA1c group. eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; MACCE, major adverse cardiovascular and cerebrovascular event; NSTE-ACS, non-ST-segment elevation acute coronary syndrome; STEMI, ST-segment elevation myocardial infarction

Back to article page